Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

209.12 -2.04 (-0.97%)
Official Closing Price Updated: 8:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why ↗
The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures. 
Via Stocktwits
Topics Intellectual Property
Why Is Fortress Biotech Stock Falling Today? ↗
Via Stocktwits
Predictive Oncology Stock Receives Significant Investor Interest Today – Here Are Two Important Developments ↗
Via Stocktwits
News headline image
Kala Bio Stock Just Plunged 92% Today – Here’s What Happened ↗
The firm stated that its KPI-012 failed in a mid-stage clinical trial and announced that it intends to preserve cash, including by laying off some of its workforce and deploying other cost-saving... 
Via Stocktwits
Topics Workforce
News headline image
Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug ↗
In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis. 
Via Stocktwits
GUTS Stock Rallied About 28% Today – Here’s Why ↗
Via Stocktwits
bioAffinity Technologies Stock Surged A Whopping 56% Today – Here’s An Important Update ↗
Via Stocktwits
Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Inside ↗
Via Stocktwits
TNF Pharmaceuticals Stock More Than Doubles After Announcing Name Change To Represent Pivot Into Quantum-Class Computing ↗
Via Stocktwits
Why Did NanoVibronix Stock Jump A Whopping 74% Today? ↗
Via Stocktwits
Helius Medical Stock Rockets 169% After Company Raises $500M To Make Solana Its Primary Treasury Asset: Retail Cheers The Deal ↗
Via Stocktwits
News headline image
Robinhood Draws Wall Street Praise Over Launch Of New Social Media Platform At HOOD Summit – More Details Inside ↗
Barclays analyst Benjamin Budish noted that Robinhood is accelerating the rollout of features, describing the updates as modern and user-friendly. 
Via Stocktwits
Topics Artificial Intelligence Economy
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗
Via Stocktwits
Professional Diversity Network Stock Exploded Over 400% Today – Here’s An Update ↗
Via Stocktwits
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗
Via Stocktwits
Soho House Nears $9-Share Go-Private Deal: Report ↗
Via Stocktwits
Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued ↗
Via Stocktwits
American Airlines Sparks Investor Debate After Q2 Beat, Cautious Outlook: Retail’s On Buying Spree ↗
Via Stocktwits
Wendy's Announces 190 New Burger Chain Outlets In Italy and Armenia: Retail View Turns Bullish ↗
Via Stocktwits
Stitch Fix Surges After William Blair Upgrade: Retail Still On The Fence ↗
Via Stocktwits
News headline image
Workhorse Group To Merge With Motive Electric Trucks: Retail’s Divided On The Combined Company Valuation ↗
The combination will create a leading North American medium-duty electric truck original equipment manufacturer with a full range of Class 4-6 trucks valued at about $105 million, the companies said. 
Via Stocktwits
Topics Electric Vehicles
News headline image
Verb Technology Stock Nearly Doubles On Monday, Retail Chatter Explodes A Whopping 1,100%: Here’s What’s Happening ↗
Following the closing of a private placement, expected on or around August 7, the company will operate under the name TON Strategy Co. (TSC). 
Via Stocktwits
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant ↗
Via Stocktwits
News headline image
Robinhood CEO Reportedly Defends OpenAI, SpaceX Tokens – Says Equity Is Not ‘Entirely Relevant’ ↗
Robinhood CEO Vlad Tenev defended offering stock tokens for OpenAI and SpaceX, saying equity status is secondary to giving retail investors access. 
Via Stocktwits
Topics ETFs Government
News headline image
BofA Lowers Crocs Price Target, But Keeps 'Buy' Rating On Potential Upside In Foreign Market ↗
Crocs' Q1 revenue and profit for the last quarter were above expectations, but the company withdrew its full-year 2025 outlook in May. 
Via Stocktwits
Topics World Trade
News headline image
Robinhood Launches Tokens For EU Users To Trade US Stocks ↗
Robinhood is expanding into Europe with tokenized stocks, crypto futures, and staking, aiming to merge traditional and digital assets through a mobile-first, blockchain-powered investment platform. 
Via Stocktwits
Topics Derivatives ETFs Lawsuit
News headline image
Cineverse Stock Soars As Terrifier 3 Lifts Q4 Revenue: Retail Optimism Abounds ↗
Cineverse Q4 revenue jumped 58% to $15.6 million, driven by Terrifier 3, with EPS and EBITDA exceeding expectations. 
Via Stocktwits
Topics Artificial Intelligence Government
News headline image
Cyngn Stocks Soars On Nvidia Partnership, Robotics Showcase ↗
The collaboration showed off Cyngn’s integration of the Nvidia Isaac robotics platform to advance its autonomous vehicle technology tailored for industrial environments. 
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
Sonim Technologies Stock Surges On AI Merger Plans With HPC Firm: Retail Turns Optimistic ↗
Shareholders of the AI infrastructure company would control a majority interest in the combined organization, while Sonim investors would retain equity worth approximately $17.5 million. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further ↗
Nektar Therapeutics said its mid-stage trial showed that patients who received Rezpegaldesleukin demonstrated improvement in eczema area and severity score compared to placebo at week 16. 
Via Stocktwits
Topics Economy Government
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.